Search details
1.
Adjuvant treatment for locally advanced gastric cancer: an Asian perspective.
Gastric Cancer
; 27(3): 439-450, 2024 05.
Article
in English
| MEDLINE | ID: mdl-38489111
2.
Factors associated with the efficacy of first-line nivolumab plus chemotherapy in advanced gastric cancer patients with deficient mismatch repair.
Gastric Cancer
; 2024 May 23.
Article
in English
| MEDLINE | ID: mdl-38780852
3.
SMARCA4-deficient undifferentiated gastric carcinoma: a case series and literature review.
Gastric Cancer
; 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38772975
4.
DNA mismatch repair deficiency and outcomes of patients with locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery plus postoperative S-1: a sub-analysis of the phase 3 PRODIGY trial.
Gastric Cancer
; 27(1): 110-117, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37889360
5.
Discordant PD-L1 results between 28-8 and 22C3 assays are associated with outcomes of gastric cancer patients treated with nivolumab plus chemotherapy.
Gastric Cancer
; 2024 Apr 22.
Article
in English
| MEDLINE | ID: mdl-38647978
6.
Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy.
Gastric Cancer
; 27(1): 146-154, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38006567
7.
Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum for metastatic, recurrent, or unresectable gastric cancer.
Gastric Cancer
; 2024 Mar 31.
Article
in English
| MEDLINE | ID: mdl-38555561
8.
A randomised phase 2 study of continuous or intermittent dosing schedule of imatinib re-challenge in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumours.
Br J Cancer
; 129(2): 275-282, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37179439
9.
Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma.
Cancer Immunol Immunother
; 72(2): 371-384, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-35902399
10.
Interruption of imatinib in advanced gastrointestinal stromal tumor after prolonged imatinib maintenance in the absence of gross tumor lesions.
Gastric Cancer
; 26(4): 604-613, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36884149
11.
Heat Treatment Enhances the Neuroprotective Effects of Crude Ginseng Saponin by Increasing Minor Ginsenosides.
Int J Mol Sci
; 24(8)2023 Apr 13.
Article
in English
| MEDLINE | ID: mdl-37108384
12.
Clinical outcomes and prognostic factors for patients with high-risk gastrointestinal stromal tumors treated with 3-year adjuvant imatinib.
Int J Cancer
; 151(10): 1770-1777, 2022 11 15.
Article
in English
| MEDLINE | ID: mdl-35678337
13.
Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma.
J Hepatol
; 77(3): 683-694, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35430299
14.
Prognostic value of natural killer cell activity for patients with HER2 + advanced gastric cancer treated with first-line fluoropyrimidine-platinum doublet plus trastuzumab.
Cancer Immunol Immunother
; 71(4): 829-838, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34420059
15.
Insertion-deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab.
Gastric Cancer
; 25(1): 226-234, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34468871
16.
Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab.
Gastric Cancer
; 25(4): 794-803, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35524883
17.
Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study.
Gastric Cancer
; 25(1): 170-179, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34476643
18.
Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study.
Gastric Cancer
; 25(6): 1039-1049, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35920999
19.
Antioxidant and Anti-Melanogenic Activities of Heat-Treated Licorice (Wongam, Glycyrrhiza glabra × G. uralensis) Extract.
Curr Issues Mol Biol
; 43(2): 1171-1187, 2021 Sep 18.
Article
in English
| MEDLINE | ID: mdl-34563052
20.
A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum ß2-microglobulin levels.
Br J Haematol
; 193(2): 307-315, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33216979